You are required to be logged in to access the full website
Click here if you have forgotten your username or password
24 December 2025 - Precision oncology company Repare Therapeutics Inc (Nasdaq: RPTX) announced on Wednesday that it has entered into a definitive asset purchase agreement with Gilead Sciences Inc for the sale of its polymerase theta ATPase inhibitor ...
24 December 2025 - Late-stage biopharmaceutical company Citius Pharmaceuticals Inc (Nasdaq:CTXR) announced on Tuesday its financial results for the fiscal year ended 30 September 2025.Citius Pharma did not report revenues for the year. The company ra...
24 December 2025 - Swiss biopharmaceutical company Bioeq AG and India-based life-sciences company Zydus Lifesciences Limited announced on Tuesday that Zydus's wholly owned subsidiary, Zydus Lifesciences Global FZE, United Arab Emirates, has form...
24 December 2025 - R&D driven, AI-powered biopharma company Sanofi (Euronext Paris: SAN) (Nasdaq: SNY) announced on Wednesday that it has agreed to acquire Dynavax Technologies Corporation (Nasdaq: DVAX) in an all-cash transaction valued at appro...
24 December 2025 - French healthcare company Sanofi S.A. (Euronext Paris:SAN) (Nasdaq:SNY) said on Wednesday that the US Food and Drug Administration (FDA) has issued a complete response letter for the new drug application for tolebrutinib in non-rel...
M2 Pharma brings you breaking news and information on the
global pharmaceuticals industry, helping you to stay one step ahead of the competition.
Click here to subscribe
Click here to subscribe